Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Methods Mol Biol ; 1227: 289-98, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25239753

RESUMO

Genomic instability tends to occur at specific genomic regions known as common fragile sites (FS). FS are evolutionarily conserved and generally involve late replicating regions with AT-rich sequences. The possible correlation between some FS and cancer-related breakpoints emphasizes on the importance of understanding the mechanisms of chromosomal instability at these sites. Although about 230 FS have already been mapped cytogenetically, only a few of them have been characterized on a molecular level. In this chapter, we provide a protocol for mapping of common FS using bacterial artificial chromosome (BAC) probes in fluorescence in situ hybridization (FISH) and suggest the usage of lymphocytes from Fanconi anemia patients as a model system. In the latter, rare FS are expressed much more frequently than in, for example, aphidicolin-induced blood lymphocyte preparations. Knowing the exact location of FS enables the molecular comparison of their location and breakpoints that appear during evolution, cancer development and inherited disorders.


Assuntos
Sítios Frágeis do Cromossomo , Cromossomos Artificiais Bacterianos/química , Anemia de Fanconi/genética , Genoma Humano , Hibridização in Situ Fluorescente/métodos , Sondas Moleculares/química , Afidicolina/toxicidade , Linhagem Celular , Mapeamento Cromossômico , Cromossomos Artificiais Bacterianos/genética , Anemia de Fanconi/metabolismo , Anemia de Fanconi/patologia , Instabilidade Genômica , Humanos , Linfócitos/química , Linfócitos/efeitos dos fármacos , Linfócitos/patologia , Sondas Moleculares/genética , Mutagênicos/toxicidade
2.
Cancer Invest ; 28(5): 459-64, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20014945

RESUMO

Distinctions between benign and malignant tumors are less evident in the central nervous system than in other tissues. Since the level of cell proliferation is an important feature in tumor grading, we applied AgNOR in 50 cases of brain tumors with different grades and histological origins in order to check its efficiency in discriminating between benign and malignant cases. We found significant differences between the means of grade I (1.76) and grade IV (2.46) tumors. No significant differences were observed considering the same grading with distinct histological types or age of patients, reinforcing the efficiency of AgNOR.


Assuntos
Neoplasias Encefálicas/patologia , Região Organizadora do Nucléolo/patologia , Coloração pela Prata , Adulto , Fatores Etários , Proteínas Cromossômicas não Histona/metabolismo , Humanos , Pessoa de Meia-Idade , Prognóstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA